期刊文献+

GBA基因与帕金森病关联机制的探讨

Possible correlation mechanisms between GBA gene and Parkinsonism
下载PDF
导出
摘要 葡萄糖脑苷脂酶基因(GBA)突变可导致戈谢病(GD),即一种常染色体隐性遗传的代谢障碍性疾病。大量临床、遗传和病理研究都证实GBA突变是帕金森病(PD)的十分重要又常见的危险因素。临床观察发现GD患者及其亲属发展为PD的概率要高于其他人群,且PD患者携带有GBA突变的频率大大增加。因此,阐明二者之间关联的机制将提高我们对PD这种常见的神经系统退行性疾病的认识,从而为其治疗提出新的见解和策略。 Mutations in the glucocerebrosidase (GBA) gene may result in Gaucher's disease (GD), which is autosomal recessive lysosomal lipid storage disorder characterized by the deficiency of the enzyme glucocerebrosidase. A number of clinical, genetic and pathological studies demonstrated that mutations in GBA are an important and common risk factor for Parkinson's disease (PD). Clinical observations showed that the patients with GD and their relatives had a higher probability of developing PD than control individuals and that the patients with PD had an increased frequency of GBA mutations when compared with the controls. Elucidating the link between GBA gene and Parkinsonism will help us to better understand PD and provide new insights into PD and potential treatment strategies.
出处 《医学争鸣》 CAS 北大核心 2015年第1期45-47,共3页 Negative
基金 国家自然科学基金(81241046)
关键词 葡萄糖脑苷脂酶基因 帕金森病 Α-突触核蛋白 glucocerebrosidase gene Parkinson's disease α-synuclein
  • 相关文献

参考文献15

  • 1Tsuang D, Leverenz JB, Lopez OL, et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology[J]. Neurology, 2012, 79(19):1944-1950.
  • 2Kong B, Yang T, Gu JW, et al. The association between lysosomal protein glucocerebrosidase and Parkinson's disease[J]. Eur Rev Med Pharmacol Sei, 2013, 17(2): 143-151.
  • 3Sidransky E, Nalls MA, Aasly JO, et al. Muhicenter analysis of glucocerebrosidase mutations in Parkinson's disease[J]. N Engl J Med, 2009, 361(17):1651-1661.
  • 4Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease inAshkenazi Jews[J]. N Engl J Med, 2004, 351(19):1972-1977.
  • 5Sidransky E, Samaddar T, Tayebi N. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset[J]. Neurology, 2009, 73(17):1424-1425, author reply: 1425-1426.
  • 6Neumann J, Bras J, Deas E, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease[J]. Brain, 2009, 132(7): 1783-1794.
  • 7Yap TL, Gruschus JM, Velayati A, et al. Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases[J]. J Biol Chem, 2011, 286(32):28080-28088.
  • 8Sardi SP, Clarke J, Kinneeom C, et al. CNS expression of glueocerebrosidase corrects alpha-synuelein pathology and memory in a mouse model of Gaucher-related synucleinopathy[J]. Proc Natl Acad Sci U S A, 2011, 108(29):12101-12106.
  • 9Manning-Bog AB, Schule B, Langston JW. Alpha-synuclein- glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism[J]. Neurotoxicology, 2009, 30(6):1127-1132.
  • 10Pacheco CD, Kunkel R, Lieberman AP. Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects[J[. Hum Mol Genet, 2007, 16(12):1495-1503.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部